WHITE PAPER
Discover novel digital assessments being developed to validate digital biomarkers in PD and how they can be applied in clinical trials.
Digital biomarkers provide real-time data on patients’ physiology and disease progression to help researchers better understand treatment efficacy.
Leading the way in digital biomarkers technology, Clinical ink offers the best-in-class analytics platform to capture, collect, and interpret real-time data powering the evaluation and development of new treatments.
Sponsors and researchers incorporating Digital Health Technologies (DHTs)—sensors and wearables—into their clinical trials are driving growth and innovation by ensuring the highest standards of data collection, transmission, security, quality, and analysis for optimal digital biomarkers. The Clinical ink platform and scalable analytics technology are essential to implementing and reinforcing these data standards.
Enable patient-centric research via mobile assessments engineered by experienced clinical, software, data, and user experience experts.
Discover novel digital assessments being developed to validate digital biomarkers in PD and how they can be applied in clinical trials.
Sales and Solutions
Direct 1.336.714.7402
Support
Toll-Free 1.800.301.5033
Direct 1.336.714.7402
Insert HTML text here.